share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰制药 | 144:拟议出售证券
美股SEC公告 ·  07/10 10:29

Moomoo AI 已提取核心信息

Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 07/10/2024, with an aggregate market value of $1,111,135.20. The shares to be sold were acquired through restricted stock vesting on two separate dates, 02/17/2024 and 02/20/2024, as part of compensation from the issuer. Over the past three months, a total of 6,840 shares have been sold by the officer, generating gross proceeds of $3,181,238.40.
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 07/10/2024, with an aggregate market value of $1,111,135.20. The shares to be sold were acquired through restricted stock vesting on two separate dates, 02/17/2024 and 02/20/2024, as part of compensation from the issuer. Over the past three months, a total of 6,840 shares have been sold by the officer, generating gross proceeds of $3,181,238.40.
Vertex Pharmaceuticals Inc.官员Carmen Bozic计划于2024年7月10日出售2,280股普通股,市场总价值为1,111,135.20美元。这些股票是作为赔偿的一部分在两个不同的日期02/17/2024和02/20/2024进行限制性股票发放后获得的。在过去的三个月中,该官员已经卖出了6,840股,总收益为3,181,238.40美元。
Vertex Pharmaceuticals Inc.官员Carmen Bozic计划于2024年7月10日出售2,280股普通股,市场总价值为1,111,135.20美元。这些股票是作为赔偿的一部分在两个不同的日期02/17/2024和02/20/2024进行限制性股票发放后获得的。在过去的三个月中,该官员已经卖出了6,840股,总收益为3,181,238.40美元。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息